Vendor Showcases


Please join SLA's Pharmaceutical & Health Technology Community as our Vendor Partners present updates. Each of the listed vendors speaks for 10 minutes and takes questions at the end of the session. This is a good opportunity to learn what's new in information and content tools in the pharma and medical devices arena. 

These sessions are appropriate for all levels of info pros in the pharmaceutical, medical devices, and healthcare fields, as well as anyone interested in learning more about information content and tools used in drug, medical device, and biosciences research.

Thanks to sponsorship from our participating vendor partners, this monthly series comes at no cost to attendees. 


May 2021 | April 2021 | March 2021 | February 2021

4th Vendor Showcase: BizInt Solutions, Dialog Solutions, EBSCO, TDNet


Day: Wednesday, May 5th, 2021
Time: 2:00PM ET (11:00AM PT)
Duration: 60 minutes
Location: Webinar

Register

Please register by clicking this link.

There is no cost for attendees of this event.

About this Event

Please join SLA's Pharmaceutical & Health Technology Community as our Vendor Partners present updates. Each of the listed vendors will speak for 10 minutes and take questions at the end of the session. This is a good opportunity to learn what's new in information and content tools in the pharma and medical devices arena. 

Thanks to sponsorship from our participating vendor partners, this monthly series comes at no cost to attendees. 

A $50 Amazon gift card will be offered by Dialog Solutions to a randomly-selected attendee.

BizInt Solutions: The BizInt Solutions team will talk about the latest features in the BizInt Smart Charts product family for creating reports and visualizations from drug pipeline, clinical trials, patent and IP sequence databases -- including support for GlobalData, our COVID-19 dashboard, and a new milestone timeline visualization in Version 12 of VantagePoint - Smart Charts Edition.

Dialog Solutions: Join our talk to learn how the Dialog platform and Dialog Alerts Manager is helping information professionals streamline their research activities. From creating an audit trail to managing and editing multiple searches at once, we’ll show you how Dialog can make your life easier, whether you’re running literature searches for compliance purposes (pharmacovigilance or EU MDR) or supporting end-user researchers.

EBSCO: Doug Hager, Lead Computational Scientist for Bayer U.S. Crop Sciences, will be presenting Bayer’s information technology portal developed in cooperation with EBSCO’s Stacks team.  Doug will identify the obstacles their Crop Sciences division had been facing, as well as the key features and benefits their new information portal offers their R&D teams. 

TDNet: In this session, Doug Madigan, Sales Manager from TDNet, Inc., will present an overview of TDNet Discover, a comprehensive platform providing a full content management system based Library Portal, Discovery Search, Link Resolver and much more. Doug will focus on new features that have been added recently to the platform.

Speakers:

BizInt Solutions: Diane Webb and the BizInt Smart Charts team

Dialog Solutions: Penny Doane-Setzer

EBSCO: S. Doug Hager

TDNet: Doug Madigan

Audience

This session is appropriate for all levels of info pros in the pharmaceutical, medical devices, and healthcare fields, as well as anyone interested in learning more about information content and tools used in drug, medical device, and biosciences research.

Presented by

Pharmaceutical & Health Technology Community

Sponsored by




return to top

3rd Vendor Showcase: BMJ, Elsevier, IBM/Watson, and Mary Ann Liebert


Day: Wednesday, April 7th, 2021

Time: 2:00PM ET (11:00AM PT)

Duration:          60 minutes

Location:          Webinar

Vendor Presentation Summaries:

BMJ: Joe Boucher

Pharma-relevant BMJ journals

BMJ's evidence-based health science journals are trusted by pharma specialists and researchers around the world. New! Exceed the limited insight of clinical trials with BMJ Case Reports - Corporate, the largest database of peer-reviewed clinical case reports available. Quickly search by drug name, specialty and disease; product demonstrations and free trials available.

Learn more about the most popular health science journals among the pharma industry. Interested? Please contact BMJ Account Manager Joe Boucher at jboucher@bmj.com or (201) 793-8195.

Elsevier:  Neal Katz; Ken Karapetyan

Elsevier’s latest version of QUOSA is a complete online information management solution designed for life sciences companies. It centralizes the process of collecting and sharing scientific information to ensure efficient and compliant use of the knowledge base. 

QUOSA is specifically developed for life sciences companies in consultation with industry information professionals. This customizable end-to-end solution can meet your most demanding scientific literature management needs without changing your existing workflows.  To learn more, please visit www.elsevier.com/quosa.

IBM/Watson Linda Elbers

DynaMed® and Micromedex® with Watson® combines evidence-based drug and disease information into a single solution. This solution was developed through a partnership between IBM and EBSCO Information Services. The combined solution features daily content updates for both drug and disease content. The Watson Assistant natural language processing capabilities are available for the drug content. Physicians and Nurse Practitioners can earn CME and CNE credits while interacting with the database. Users can ‘follow’ specific topics of interest and be notified when there are new updates available. There is a mobile app to supplement the online solution. Dynamed and Micromedex with Watson brings to the market a comprehensive alternative for a combined drug and disease resource with a lower cost of ownership.

Mary Ann Liebert:  Matthew Haberman

Founded by Mary Ann Liebert in the corner of her living room in 1980, Mary Ann Liebert, Inc. is one of the only remaining independent STM publishers.  Mary Ann Liebert, Inc. create first-to-market, specialized publications that play a vital role in advancing research in cutting-edge fields such as biotechnology, public health, life sciences, clinical medicine and surgery.

return to top

 
2nd Vendor Showcase: Copyright Clearance Center, Pharmintell, and Springer Nature, adisinsight


Day:                 Wednesday, March 10, 2021

Time:                2:00 pm EST (11:00 am PT)

Duration:          60 minutes

Location:          Webinar

Speakers:

  •  Copyright Clearance Center:  Keri Mattiliano
  •  PharmIntell:  Michelle Eindhoven & Donna Sees
  •  Springer Nature, AdisInsight:  Angela Panetta

Summaries:

Copyright Clearance Center

Life science companies are looking to turn information into knowledge to accelerate the pace of innovation. But, with an average 8,000 scientific articles published every day, finding relevant, trusted information to stay on top of the latest research and connect information to discover new relationships isn’t easy. RightFind Insight, powered by SciBite, brings semantic enrichment to the search and reading experience to turn information into knowledge to accelerate new discoveries. With RightFind Insight, researchers can

  • Find the relevant scientific concepts faster in scientific literature
  • Quickly determine if a full-text document is relevant to your work before investing time and resources reading the document
  • Reveal undiscovered connections across vast amounts of content to expose new insights
  • Simplify search and discovery with automatic synonym expansion and homonym resolution
  • Showcase the strategic value of information services by leveraging state-of-the-art semantic enrichment technology

 

RightFind Insight is powered by the SciBite platform, including hand-curated vocabularies/ontologies and the ultra-fast named entity recognition extraction engine TERMite®. With a simple and intuitive interface, this rich and easy to use search experience brings scientific concepts to the forefront of literature by semantically enriching 120 million citations and 17 million full-text articles in the RightFind catalog and the content in your personal and shared libraries. RightFind Insight features

  • Semantic search – Get relevant documents with a comprehensive search that incorporates more than 36 of SciBite’s biomedical vocabularies including more than 20 million synonyms.
  • Full-text keyword preview – Instantly zero in on highlighted keywords to quickly determine if a full-text document is relevant to your work before ordering it.  
  • Synonym type ahead – Go beyond keyword searching with automatic synonym expansion and homonym resolution.  
  • Semantic visualization – Reveal hidden information with dynamic visualizations to discover connections between biomedical concepts and extract insights.  
  • On-the-fly document enrichment – View highlighted terms from more than 36 of SciBite’s biomedical vocabularies with more than 20 million synonyms to navigate to relevant sections of the full text article.
  • Semantically enriched search results – Run literature searches for colleagues and share the results via an Excel, PDF, or HTML file to deliver relevant content, or share curated citations from literature searches in a shared library or search alert with colleagues who have similar interests.

 

To learn more about RightFind Insight, please visit our website or contact us today!





Adis Insight

Many SLA members are familiar with the AdisInsight database which is often searched to obtain the latest details regarding drug development and associated clinical trial information. During the SLA-PHT Webinar, we discussed more use cases, which users might be less familiar with, related to AdisInsight Safety and the AdisInsight Data feed.

AdisInsight Safety is a tool that can help improve the efficiency of in-house pharmacovigilance literature monitoring. Our Safety content set is a database of validated adverse events and special situation Individual Case Safety Reports, or ICSRs, for drugs.  AdisInsight Safety can help you identify, monitor, and report the published ICSRs that you need to know about. The AdisInsight database allows subscribers to easily create strategies to yield the search results they need to pinpoint.

The AdisInsight data feed enables users to directly access AdisInsight Drug and Trial content through an XML data feed either daily, weekly, or monthly. Typically, a data feed could be used by Digital Librarians to integrate AdisInsight content into an organization’s’ information portal. Or, an Information Manager might use the AdisInsight data feed as source material to support data mining activities. Lastly, a Data Scientist might use a data feed to support big data analysis where direct content is more convenient than platform access. An AdisInsight data feed enables an organization to integrate external content alongside internal, company content.

To learn more about AdisInsight, please visit AdisInsight.Springer.com or email Angela.Panetta@springer.com for more information.





PharmIntell

Michelle Eindhoven and Donna Sees, co-owners of PharmIntell Consulting LLC, gave a brief introduction to the company. PharmIntell is a WBENC-certified, women-owned small business providing information services to the pharmaceutical, medical device and biomedical industries. Founded in 2006 by former SLA member Kerry Kushinka, it has grown into a robust team of 25 experienced info pros. PharmIntell’s core competencies include literature searching, competitive intelligence, and library services. PharmIntell offers multiple solutions and service models, whether project-based, short-term or long-term, on-site or off-site, to support the varied information needs of its industry clients.




return to top

1st Vendor Showcase: SPRINGER NATURE, WOLTERS KLUWER, THE NEW ENGLAND JOURNAL OF MEDICINE GROUP, AND TAYLOR & FRANCIS


Day: February 17th, 2021

Time: 2:00PM ET (11:00 AM PT)

Duration: 60 minutes

Location: Webinar

Springer Nature 
www.springernature.com

Speaker: Christina Sontag

Springer Nature is one of the world’s leading global research, educational and professional publishers, home to an array of respected and trusted brands providing quality content through a range of innovative products and services.

Springer Nature provided an update on their text & data mining offerings, as well as some exciting new reporting options via Google BigQuery for Dimensions, a networked view of interconnected scientific, medical, and technical data that can be used to track research and discovery trends.





New England Journal of Medicine Group  www.nejmgroup.org

Speaker: David Kipp
NEJM Group creates high-quality medical resources for research, learning, practice and professional development designed to meet the demand for essential medical knowledge among intermediaries who serve the research and medical communities, e.g., publishing, technology and pharmaceutical organizations, academic researchers and teachers, physicians, clinicians, executives and others in medicine and healthcare. NEJM Group products include the New England Journal of Medicine, NEJM Catalyst Innovations in Care Delivery, and NEJM Journal Watch. NEJM Group is a division of the Massachusetts Medical Society.

NEJM provided updates in three areas:

  1. The New England Journal of Medicine:

We have expanded and improved many of our research tools that accompany our original research articles on NEJM.org.  Users should be aware of these tools as they are great summaries and are an easy way to briefly communicate the make up of the in-depth article.  These include:

Quik Take Video – 2-3 minute professional videos that summarize the key components of a study.  They are located in the article and also in the Multimedia Section of NEJM.org.

Visual Abstracts – single page infographic that summarizes the findings of a study.

Research Summary – one page outline that briefly describes the problem studied, trial makeup, results and conclusion.  These are available with some trials now and eventually, will be provided with every clinical trial published.

  1. NEJM Catalyst:

NEJM introduced this journal last year and we have had a great response.  We publish long form, peer-reviewed articles and other content that deals with the latest issues and innovations that transform health care delivery.  This year we will move to a monthly format.  Many key articles have been of particular interest to the pharmaceutical industry.  Key management functions that deal with new and transformative models should be consulted to see the value that this journal provides.

  1. NEJM announcing a new journal offering for January, 2022:

NEJM Evidence will be rolled out next year to help change the process and delivery of publishing key clinical trials.  The emphasis will be on better understanding of the trial process, more input and participation of authors and readers on the work being done, and encouragement of clinicians to demand new evidence to challenge the status quo towards better decision making.  Dr. Jeff Drazen (former editor of The New England Journal of Medicine) will be editor of NEJM Evidence and will use the same trusted editorial rigor in helping to develop new ways to understand and discuss studies that can improve patient care.  More information on NEJM Evidence will be available over the next few months.



Wolters Kluwer    www.wolterskluwer.com

Speakers: Ian Bergin and Glenn McAlpine
Wolters Kluwer is a leading global provider of trusted clinical technology and evidence-based solutions that help healthcare professionals build clinical competency and effective decision-making to improve outcomes.

Wolters Kluwer's presentation on new and upcoming platform updates featured a live demonstration of two new functionalities (Term Finder & Search Sharing) that debuted in 2020 as a result of a formal contextual inquiry process, in which Wolters Kluwer's product development team members observe user behavior in the field with existing technologies to help them​:

 

  • Understand the jobs users do​
  • Identify users’ unmet needs​
  • Understand the vocabulary users use to describe things​
  • Identify how customers think about a problem 

 

The new integrated Ovid Term Finder tool allows users to quickly and easily build a complex search strategy (incorporating MeSH Subject headings, Used for Terms, Scope Note, Subheadings, Permuted Index and UMLS Terms) without leaving the advanced search mode of Ovid Medline.  And the new Search Sharing options (currently in Beta) allows users to seamlessly share search strategies with colleagues, allowing the recipient to rerun the search with one click. 

 

Ovid Search Builder and Ovid Discovery were also briefly described as well as planned new Ovid features scheduled for 2021 release.




Taylor & Francis   https://www.tandfonline.com

Speakers: Dani Cargill and Mary Yianni 

T&F harnesses the solution to your medical research access needs. Our known Expert Collection is the gateway to cutting edge discussion and debate with systematic, autoreactive analysis and insightful commentary from international experts. Our services include Fast Track and Rabid Track submission to online publication as well as reprints, e-prints and video and graphical abstracts. Access our journals on the article level with Article Pass or subscribe to a collection today. Our new live release includes enhancements such as Enriched SEO metadata on Article pages, improved branding on institutional accounts, new ‘Further reading’ related articles widget, and new TOC page sorting & filtering options. Contact Corporate Sales Manager Dani Cargill for more information at dani.cargill@taylorandfrancis.com.




 return to top